Vaagenes H, Madsen L, Dyrøy E, Elholm M, Stray-Pedersen A, Frøyland L, Lie O, Berge R K
Department of Clinical Biochemistry, University of Bergen, Haukeland Hospital, Norway.
Biochem Pharmacol. 1999 Oct 1;58(7):1133-43. doi: 10.1016/s0006-2952(99)00198-7.
We introduced methyl or ethyl groups to the 2- or 3-position of the eicosapentaenoic acid (EPA) molecule to investigate whether the branching of EPA could influence its hypolipidemic effect in rats. The most effective branching involved two methyl groups in the 2-position and one methyl group in the 3-position. These EPA derivatives increased hepatic mitochondrial and peroxisomal beta-oxidation and decreased plasma lipids concomitant with suppressed acetyl-coenzyme A (CoA) carboxylase (EC 6.4.1.2) and fatty acid synthase (EC 2.3.1.85) activities. This was followed by elevated activities of camitine O-palmitoyltransferase (EC 2.3.1.21) and possibly 2,4-dienoyl-CoA reductase (EC 1.3.1.34), as well as induced mRNA levels of these enzymes and fatty acyl-CoA oxidase. The fatty acid composition in liver changed, with an increased 18:1 n-9 content, whereas the expression of delta9-desaturase remained unchanged. We investigated the flux of fatty acids in cultured hepatocytes, and found that oxidation of [1-14C]-labeled palmitic acid increased but the secretion of palmitic acid-labeled triglycerides decreased after addition of 2-methyl-EPA. The fatty acyl-CoA oxidase (EC 1.3.3.6) activity in these cells remained unchanged. A significant negative correlation was obtained between palmitic acid oxidation and palmitic acid-labeled synthesized triglycerides. To investigate whether the hypolipidemic effect occurred independently of induced peroxisomal beta-oxidation, we fed rats 2-methyl-tetradecylthioacetic acid. This compound increased the peroxisomal but not the mitochondrial beta-oxidation, and the plasma lipid levels were unchanged. In conclusion, EPA methylated in the 2- or 3-position renders it more potent as a hypolipidemic agent. Furthermore, this study supports the hypothesis that the mitochondrion is the primary site for the hypolipidemic effect.
我们将甲基或乙基引入二十碳五烯酸(EPA)分子的2位或3位,以研究EPA的支链是否会影响其对大鼠的降血脂作用。最有效的支链是在2位有两个甲基且在3位有一个甲基。这些EPA衍生物增加了肝线粒体和过氧化物酶体的β-氧化,降低了血浆脂质,同时抑制了乙酰辅酶A(CoA)羧化酶(EC 6.4.1.2)和脂肪酸合酶(EC 2.3.1.85)的活性。随后肉碱O-棕榈酰转移酶(EC 2.3.1.21)以及可能的2,4-二烯酰-CoA还原酶(EC 1.3.1.34)的活性升高,这些酶和脂肪酸酰基-CoA氧化酶的mRNA水平也升高。肝脏中的脂肪酸组成发生了变化,18:1 n-9含量增加,而δ9-去饱和酶的表达保持不变。我们研究了培养的肝细胞中脂肪酸的通量,发现添加2-甲基-EPA后,[1-14C]标记的棕榈酸氧化增加,但棕榈酸标记的甘油三酯分泌减少。这些细胞中的脂肪酸酰基-CoA氧化酶(EC 1.3.3.6)活性保持不变。棕榈酸氧化与棕榈酸标记的合成甘油三酯之间存在显著的负相关。为了研究降血脂作用是否独立于诱导的过氧化物酶体β-氧化而发生,我们给大鼠喂食2-甲基十四烷基硫代乙酸。该化合物增加了过氧化物酶体的β-氧化,但未增加线粒体的β-氧化,血浆脂质水平未改变。总之,在2位或3位甲基化的EPA作为降血脂剂更有效。此外,本研究支持线粒体是降血脂作用的主要部位这一假说。